-
1.发明申请公开(公告)号：US20180140603A1
公开(公告)日：2018-05-24
申请号：US15861444
申请日：2018-01-03
Applicant: Array BioPharma Inc.
Inventor： Donald T. Corson , Christopher M. Lindemann , Daniel J. Watson
IPC: A61K31/517 , A61K45/06 , C07D471/04
CPC classification number: A61K31/517 , A61K31/437 , A61K45/06 , A61P35/00 , C07D471/04
Abstract: Polymorphs of N4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine are provided herein. Processes for preparing the polymorphs and pharmaceutical composition comprising the polymorphs are also disclosed.
-
2.发明授权公开(公告)号：US11571424B2
公开(公告)日：2023-02-07
申请号：US16942094
申请日：2020-07-29
Applicant: Array BioPharma Inc.
Inventor： Donald T. Corson , Christopher M. Lindemann , Daniel J. Watson
IPC: A61K31/517 , A61K31/437 , A61P35/00 , C07D471/04 , A61K45/06
Abstract: Polymorphs of N4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine are provided herein. Processes for preparing the polymorphs and pharmaceutical composition comprising the polymorphs are also disclosed.
-
3.发明申请POLYMORPHS OF ARRY-380, A SELECTIVE HER 2 INHIBITOR AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM 有权ARRY-380的多聚体，选择性的2抑制剂和含有它们的药物组合物公开(公告)号：US20160175309A1
公开(公告)日：2016-06-23
申请号：US14923172
申请日：2015-10-26
Applicant: Array BioPharma Inc.
Inventor： Donald T. Corson , Christopher M. Lindemann , Daniel J. Watson
IPC: A61K31/517 , A61K45/06
CPC classification number: A61K31/517 , A61K31/437 , A61K45/06 , A61P35/00 , C07D471/04
Abstract: Polymorphs of N4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine are provided herein. Processes for preparing the polymorphs and pharmaceutical composition comprising the polymorphs are also disclosed.
Abstract translation: N 4 - （4 - （[1,2,4]三唑并[1,5-a]吡啶-7-基氧基）-3-甲基苯基）-N6-（4,4-二甲基-4,5-二氢恶唑-2-基） 吡啶-2-基）喹唑啉-4,6-二胺。 还公开了制备多晶型物的方法和包含多晶型物的药物组合物。
-
4.发明申请公开(公告)号：US20210077493A1
公开(公告)日：2021-03-18
申请号：US16942094
申请日：2020-07-29
Applicant: Array BioPharma Inc.
Inventor： Donald T. Corson , Christopher M. Lindemann , Daniel J. Watson
IPC: A61K31/517 , A61K31/437 , A61P35/00 , C07D471/04 , A61K45/06
Abstract: Polymorphs of N4-(4-([1,2,4]triazolo[1,5 -a]pyridin-7-yloxy)-3 -methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine are provided herein. Processes for preparing the polymorphs and pharmaceutical composition comprising the polymorphs are also disclosed.
-
5.发明公开公开(公告)号：US20230241066A1
公开(公告)日：2023-08-03
申请号：US18092731
申请日：2023-01-03
Applicant: Array BioPharma Inc.
Inventor： Donald T. Corson , Christopher M. Lindemann , Daniel J. Watson
IPC: A61K31/517 , A61P35/00 , C07D471/04 , A61K31/437 , A61K45/06
CPC classification number: A61K31/517 , A61P35/00 , C07D471/04 , A61K31/437 , A61K45/06
Abstract: Polymorphs of N4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine are provided herein. Processes for preparing the polymorphs and pharmaceutical composition comprising the polymorphs are also disclosed.
-
Patent Agency Ranking
![POLYMORPHS OF ARRY-380, A SELECTIVE HER[[B]]2 INHIBITOR AND PHARMACEUTICAL COMPOSITIONS CONT[[l]]AINING THEM](/abs-image/US/2019/05/02/US20190125749A1/abs.jpg.150x150.jpg)
6.发明申请公开(公告)号：US20190125749A1
公开(公告)日：2019-05-02
申请号：US16169937
申请日：2018-10-24
Applicant: Array BioPharma Inc.
Inventor： Donald T. Corson , Christopher M. Lindemann , Daniel J. Watson
IPC: A61K31/517 , A61K45/06 , A61K31/437 , A61P35/00 , C07D471/04
Abstract: Polymorphs of N4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-N6-(4,4-dimethyl-4, 5-dihydrooxazol-2-yl)quinazoline-4,6-diamine are provided herein. Processes for preparing the polymorphs and pharmaceutical composition comprising the polymorphs are also disclosed.
-
7.发明授权公开(公告)号：US09889134B2
公开(公告)日：2018-02-13
申请号：US14923172
申请日：2015-10-26
Applicant: Array BioPharma Inc.
Inventor： Donald T. Corson , Christopher M. Lindemann , Daniel J. Watson
IPC: C07D471/04 , A61K31/437 , A61K31/517 , A61K45/06 , A61P35/00
CPC classification number: A61K31/517 , A61K31/437 , A61K45/06 , A61P35/00 , C07D471/04
Abstract: Polymorphs of N4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine are provided herein. Processes for preparing the polymorphs and pharmaceutical composition comprising the polymorphs are also disclosed.
-
8.发明授权公开(公告)号：US10765678B2
公开(公告)日：2020-09-08
申请号：US16169937
申请日：2018-10-24
Applicant: Array BioPharma Inc.
Inventor： Donald T. Corson , Christopher M. Lindemann , Daniel J. Watson
IPC: C07D471/04 , A61K31/437 , A61K31/517 , A61P35/00 , A61K45/06
Abstract: Polymorphs of N4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine are provided herein. Processes for preparing the polymorphs and pharmaceutical composition comprising the polymorphs are also disclosed.
-
9.发明授权公开(公告)号：US10143692B2
公开(公告)日：2018-12-04
申请号：US15861444
申请日：2018-01-03
Applicant: Array BioPharma Inc.
Inventor： Donald T. Corson , Christopher M. Lindemann , Daniel J. Watson
IPC: C07D471/04 , A61K31/437 , A61K31/517 , A61P35/00 , A61K45/06
Abstract: Polymorphs of N4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine are provided herein. Processes for preparing the polymorphs and pharmaceutical composition comprising the polymorphs are also disclosed.
-
10.发明授权Polymorphs of ARRY-380, a selective HER 2 inhibitor and pharmaceutical compositions containing them 有权ARRY-380，选择性HER2抑制剂和含有它们的药物组合物的多晶型物公开(公告)号：US09168254B2
公开(公告)日：2015-10-27
申请号：US14351835
申请日：2012-10-12
Applicant: Array BioPharma Inc.
Inventor： Donald T. Corson , Christopher M. Lindemann , Daniel J. Watson
IPC: C07D471/04 , A61K31/437 , A61K31/517 , A61K45/06
CPC classification number: A61K31/517 , A61K31/437 , A61K45/06 , A61P35/00 , C07D471/04
Abstract: Polymorphs of N4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine are provided herein. Processes for preparing the polymorphs and pharmaceutical composition comprising the polymorphs are also disclosed.
Abstract translation: N 4 - （4 - （[1,2,4]三唑并[1,5-a]吡啶-7-基氧基）-3-甲基苯基）-N6-（4,4-二甲基-4,5-二氢恶唑-2-基） 吡啶-2-基）喹唑啉-4,6-二胺。 还公开了制备多晶型物的方法和包含多晶型物的药物组合物。
-
-
-
-
-
-
-
-
-
Search Results
12
records
(took 0.017 seconds)
